India and the international biosafety law: a critical legal appraisal of the Biotechnology Regulatory Authority of India Bill, 2013
by S.R. Subramanian; A. Saravanan; S.R. Sethu Narayanan
International Journal of Private Law (IJPL), Vol. 8, No. 2, 2015

Abstract: In the case of biotechnology, one of the major challenges in the process of regulation is to establish and maintain an appropriate balance between potential benefits of the technology and environmental and health risks posed by it. Though this dilemma has been resolved to a certain extent, owing to the provisions of the Cartagena Protocol on Biosafety in the evaluation and the management of risks, the contracting parties face several difficulties and challenges in the development of the legal framework implementing the international obligations at the national level. It is in this connection, the paper attempts to find out how biotechnology is currently regulated in India and how it is proposed to be regulated under the Biotechnology Regulatory Authority of India (BRAI) Bill, 2013.

Online publication date: Tue, 17-May-2016

The full text of this article is only available to individual subscribers or to users at subscribing institutions.

 
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.

Pay per view:
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.

Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Private Law (IJPL):
Login with your Inderscience username and password:

Username:        Password:          Forgotten your password?

Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.

If you still need assistance, please email subs@inderscience.com